Overexpression of receptor for advanced glycation end products and high-mobility group box 1 in human dental pulp inflammation

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Tancharoen, Salunya ^a   Tengrungsun, Tassanee ^a   Suddhasthira, Theeralaksna ^a   Kikuchi, Kiyoshi ^b   Vechvongvan, Nuttavun ^c   Tokuda, Masayuki ^d   Maruyama, Ikuro ^d  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Oral and Maxillofacial Surgery Faculty of Dentistry Mahidol University ^*  (Thailand)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B; LIPOPOLYSACCHARIDE; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; GENE OVEREXPRESSION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; ODONTOBLAST; PATHOGENESIS; PREVOTELLA INTERMEDIA; PROTEIN EXPRESSION; PULPITIS; STIMULATION; UPREGULATION; CELL CULTURE; GENETICS; IMMUNOLOGY; IN VITRO STUDY; INFLAMMATION; METABOLISM; PATHOLOGY; TOOTH PULP;

CELLS, CULTURED; DENTAL PULP; HMGB1 PROTEIN; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION; RECEPTORS, IMMUNOLOGIC;

EID: 84904605564     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/754069     Document Type: Article

References (67)

1. Farges J. C., Alliot-Licht B., Baudouin C., Msika P., Bleicher F., Carrouel F., Odontoblast control of dental pulp inflammation triggered by cariogenic bacteria. Frontiers in Physiology 2013 4, article 326
2. Laurent P., Camps J., About I., BiodentineTM induces TGF- β 1 release from human pulp cells and early dental pulp mineralization. International Endodontic Journal 2012 45 5 439 448 10.1111/j.1365-2591.2011. 01995.x 2-s2.0-84859498464
3. Veerayutthwilai O., Byers M. R., Pham T.-T., Darveau R. P., Dale B. A., Differential regulation of immune responses by odontoblasts. Oral Microbiology and Immunology 2007 22 1 5 13 10.1111/j.1399-302X.2007.00310.x 2-s2.0-33846260753 (Pubitemid 46096190)
4. Li P., Xue Y., Zhang W., Yu Q., Sun Y., Qu T., Chen X., Cheng X., Song B., Luo W., Teng F., Sodium fluoride induces apoptosis in odontoblasts via a JNK-dependent mechanism. Toxicology 2013 308 138 145 10.1016/j.tox.2013.03.016 2-s2.0-84877020844
5. Haapasalo M., Ranta H., Ranta K., Shah H., Black-pigmented Bacteroides spp. in human apical periodontitis. Infection and Immunity 1986 53 1 149 153 2-s2.0-0022483206 (Pubitemid 16084378)
6. Morrison D. C., Ryan J. L., Endotoxins and disease mechanisms. Annual Review of Medicine 1987 38 417 432 10.1146/annurev.me.38.020187.002221 2-s2.0-0023079312
7. Tokuda M., Sakuta T., Fushuku A., Torii M., Nagaoka S., Regulation of interleukin-6 expression in human dental pulp cell cultures stimulated with Prevotella intermedia lipopolysaccharide. Journal of Endodontics 2001 27 4 273 277 10.1097/00004770-200104000-00008 2-s2.0-0035317549 (Pubitemid 33753621)
8. Nagaoka S., Tokuda M., Sakuta T., Taketoshi Y., Tamura M., Takada H., Kawagoe M., Interleukin-8 gene expression by human dental pulp fibroblast in cultures stimulated with Prevotella intermedia lipopolysaccharide. Journal of Endodontics 1996 22 1 9 12 10.1016/S0099-2399(96)80228-7 2-s2.0-0029688640 (Pubitemid 126730184)
9. Coil J., Tam E., Waterfield J. D., Proinflammatory cytokine profiles in pulp fibroblasts stimulated with lipopolysaccharide and methyl mercaptan. Journal of Endodontics 2004 30 2 88 91 2-s2.0-1542427754 (Pubitemid 38650757)
10. Stashenko P., Teles R., D'Souza R., Periapical inflammatory responses and their modulation. Critical Reviews in Oral Biology and Medicine 1998 9 4 498 521 10.1177/10454411980090040701 2-s2.0-0032321488 (Pubitemid 29402013)
11. Bletsa A., Berggreen E., Fristad I., Tenstad O., Wiig H., Cytokine signalling in rat pulp interstitial fluid and transcapillary fluid exchange during lipopolysaccharide-induced acute inflammation. Journal of Physiology 2006 573 1 225 236 10.1113/jphysiol.2006.104711 2-s2.0-33646340412 (Pubitemid 43670870)
12. Schmidt A. M., Hofmann M., Taguchi A., Stern D. M., RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation. Seminars in Thrombosis and Hemostasis 2000 26 5 485 493 10.1055/s-2000-13204 2-s2.0-0033635831
13. Schmidt A. M., Stern D. M., Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease. Frontiers in Bioscience 2001 6 D1151 D1160 10.2741/Schmidt 2-s2.0-1242290096
14. Neeper M., Schmidt A. M., Brett J., Wang F., Pan Y.-. E., Elliston K., Stern D., Shaw A., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. The Journal of Biological Chemistry 1992 267 21 14998 15004 2-s2.0-0026659883
15. Hori O., Brett J., Slattery T., Cao R., Zhang J., Nagashima M., Lundh E. R., Vijay S., Nitecki D., Morser J., Stern D., Schmidt A. M., The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. The Journal of Biological Chemistry 1995 270 43 25752 25761 10.1074/jbc.270.43.25752 2-s2.0-0028851635
16. Hofmann M. A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M. F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., Schmidt A. M., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999 97 7 889 901 10.1016/S0092-8674(00)80801-6 2-s2.0-0033603241 (Pubitemid 29375048)
17. Bierhaus A., Humpert P. M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D. M., Nawroth P. P., Understanding RAGE, the receptor for advanced glycation end products. Journal of Molecular Medicine 2005 83 11 876 886 10.1007/s00109-005-0688-7 2-s2.0-27744453362 (Pubitemid 41598688)
18. Schmidt A. M., Yan S. D., Yan S. F., Stern D. M., The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. The Journal of Clinical Investigation 2001 108 7 949 955 10.1172/JCI200114002 2-s2.0-0034795140 (Pubitemid 32946067)
19. Fiuza C., Bustin M., Talwar S., Tropea M., Gerstenberger E., Shelhamer J. H., Suffredini A. F., Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003 101 7 2652 2660 10.1182/blood-2002- 05-1300 2-s2.0-0037769813 (Pubitemid 36857626)
20. Andersson U., Wang H., Palmblad K., Aveberger A., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., Tracey K. J., High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. Journal of Experimental Medicine 2000 192 4 565 570 10.1084/jem.192.4.565 2-s2.0-0034698830 (Pubitemid 30666257)
21. Taniguchi N., Kawahara K., Yone K., Hashiguchi T., Yamakuchi M., Goto M., Inoue K., Yamada S., Ijiri K., Matsunaga S., Nakajima T., Komiya S., Maruyama I., High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis and Rheumatism 2003 48 4 971 981 10.1002/art.10859 2-s2.0-0037386810 (Pubitemid 36418239)
22. Oyama Y., Hashiguchi T., Taniguchi N., Tancharoen S., Uchimura T., Biswas K. K., Kawahara K., Nitanda T., Umekita Y., Lotz M., Maruyama I., High-mobility group box-1 protein promotes granulomatous nephritis in adenine-induced nephropathy. Laboratory Investigation 2010 90 6 853 866 10.1038/labinvest.2010. 64 2-s2.0-77954566533
23. Kikuchi K., Miura N., Morimoto Y., HMGB1 as a therapeutic target in spinal cord injury: a hypothesis for novel therapy development. Experimental and Therapeutic Medicine 2011 2 767 770
24. Morimoto Y., Tancharoen S., Kikuchi K., Matsuyama T., Hashiguchi T., Izumi Y., Maruyama I., Tumor necrosis factor- α stimulates gingival epithelial cells to release high mobility-group box 1. Journal of Periodontal Research 2008 43 1 76 83 10.1111/j.1600-0765.2007.00996.x 2-s2.0-38349185374
25. Okuma Y., Wake H., Zhang J., Liu K., Maruo T., Date I., Yoshino T., Ohtsuka A., Otani N., Tomura S., Shima K., Yamamoto Y., Yamamoto H., Takahashi H. K., Mori S., Nishibori M., Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Annals of Neurology 2012 72 3 373 384 10.1002/ana.23602 2-s2.0-84867101159
26. Kikuchi K., Tancharoen S., Ito T., Morimoto-Yamashita Y., Miura N., Kawahara K., Maruyama I., Murai Y., Tanaka E., Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke. International Journal of Molecular Sciences 2013 14 18899 18924
27. Okuma Y., Liu K., Wake H., Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Annals of Neurology 2012 7 3 373 384 10.1002/ana.23602
28. Sawa H., Takeyama Y., Yasuda T., Shinzeki M., Nakajima T., Kuroda Y., Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World Journal of Gastroenterology 2006 12 47 7666 7670 2-s2.0-33845989093 (Pubitemid 46040580)
29. Liu Z., Falo L. D. Jr., You Z., Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunity. Journal of Immunology 2011 187 1 118 125 10.4049/jimmunol.1003378 2-s2.0-79960387864
30. Tamura M., Tokuda M., Nagaoka S., Takada H., Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures. Infection and Immunity 1992 60 11 4932 4937 2-s2.0-0026456982
31. Hamada S., Koga T., Nishihara T., Fujiwara T., Okahashi N., Characterization and immunobiologic activities of lipopolysaccharides from periodontal bacteria. Advances in Dental Research 1988 2 2 284 291 2-s2.0-0024109552
32. McLachlan J. L., Sloan A., Cooper P. R., Gene expression analysis of genes of the dentine pulp complex in healthy and carious teeth. Archives of Oral Biology 2003 48 273 283 (Pubitemid 36499879)
33. McLachlan J. L., Smith A. J., Bujalska I. J., Cooper P. R., Gene expression profiling of pulpal tissue reveals the molecular complexity of dental caries. Biochimica et Biophysica Acta 2005 1741 3 271 281 10.1016/j.bbadis. 2005.03.007 2-s2.0-25144512524 (Pubitemid 41338673)
34. Arany S., Nakata A., Kameda T., Koyota S., Ueno Y., Sugiyama T., Phenotype properties of a novel spontaneously immortalized odontoblast-lineage cell line. Biochemical and Biophysical Research Communications 2006 342 3 718 724 10.1016/j.bbrc.2006.02.020 2-s2.0-33644627315 (Pubitemid 43320458)
35. Heid C. A., Stevens J., Livak K. J., Williams P. M., Real time quantitative PCR. Genome research 1996 6 10 986 994 10.1101/gr.6.10.986 (Pubitemid 26388091)
36. Pichiule P., Schmidt A., Vannucci S., Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia. The Journal of Biological Chemistry 2007 282 36330 36340
37. Nawa Y., Kawahara K.-I., Tancharoen S., Meng X., Sameshima H., Ito T., Masuda Y., Imaizumi H., Hashiguchi T., Maruyama I., Nucleophosmin may act as an alarmin: implications for severe sepsis. Journal of Leukocyte Biology 2009 86 3 645 653 10.1189/jlb.1008644 2-s2.0-70149116131
38. He Z., Wang Z., Chen Y., Shen Q., Dai S., HMGB1 acts in synergy with lipopolysaccharide in activating rheumatoid synovial fibroblasts via p38 MAPK and NF- B signaling pathways. Mediators of Inflammation 2013 2013 10 596716 10.1155/2013/596716
39. Podolin P. L., Callahan J. F., Bolognese B. J., Li Y. H., Carlson K., Davis T. G., Mellor G. W., Evans C., Roshak A. K., Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IkappaB kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4- fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation. Journal of Pharmacology and Experimental Therapeutics 2005 312 1 373 381 10.1124/jpet.104.074484 2-s2.0-11844305963 (Pubitemid 40096491)
40. Karapanou V., Kempuraj D., Theoharides T. C., Oral neuroimmune network and mast cells. European Journal of Inflammation 2009 7 1 1 8 2-s2.0-65549160577
41. Hamada S., Takada H., Ogawa T., Fujiwara T., Mihara J., Lipopolysaccharides of oral anaerobes associated with chronic inflammation: chemical and immunomodulating properties. International Reviews of Immunology 1990 6 4 247 261 10.3109/08830189009056635 2-s2.0-0025655384
42. Kirikae T., Nitta T., Kirikae F., Suda Y., Kusumoto S., Qureshi N., Nakano M., Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infection and Immunity 1999 67 4 1736 1742 2-s2.0-0033057903 (Pubitemid 29144391)
43. Hashimoto M., Asai Y., Tamai R., Jinno T., Umatani K., Ogawa T., Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide. The FEBS Letters 2003 543 1 98 102 10.1016/S0014-5793(03)00414-9 2-s2.0-0038731135 (Pubitemid 36577235)
44. Choi E. Y., Choi J., Choi I., Kim S., DHA sup presses Prevotella intermedia lipopolysaccharide -induced production of proinflammatory med iators in murine macrophages. British Journal of Nutrition 2013 19 1 10 10.1111/jre.12054 2-s2.0-84874245921
45. Pelt P., Zimmermann B., Ulbrich N., Bernimoulin J.-P., Effects of lipopolysaccharide extracted from Prevotella intermedia on bone formation and on the release of osteolytic mediators by fetal mouse osteoblasts in vitro. Archives of Oral Biology 2002 47 12 859 866 10.1016/S0003-9969(02)00150-4 2-s2.0-0036885659 (Pubitemid 41123018)
46. Funayama H., Mayanagi H., Takada H., Endo Y., Inflammatory reactions in extraoral tissues in mice after intragingival injection of lipopolysaccharide. Journal of Infectious Diseases 2001 184 12 1566 1571 10.1086/324663 2-s2.0-0035893004 (Pubitemid 33139742)
47. Wang H., Vishnubhakat J. M., Bloom O., Zhang M., Ombrellino M., Sama A., Tracey K. J., Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999 126 2 389 392 10.1016/S0039-6060(99)70182-0 2-s2.0-0032816123 (Pubitemid 29382808)
48. Scaffidi P., Misteli T., Bianchi M. E., Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002 418 6894 191 195 2-s2.0-77957373826 (Pubitemid 34773774)
49. Gardella S., Andrei C., Ferrera D., Lotti L. V., Torrisi M. R., Bianchi M. E., Rubartelli A., The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. The EMBO Reports 2002 3 10 995 1001 10.1093/embo-reports/kvf198 2-s2.0-0036775236 (Pubitemid 35256475)
50. Chen Y., Gao R., Su Y., Umehara H., Dong L., Gong F., The role of high mobility group box chromosomal protein 1 in rheumatoid arthritis. Rheumatology (Oxford) 2013 52 10 1739 1747
51. Gardella S., Andrei C., Ferrera D., Lotti L. V., Torrisi M. R., Bianchi M. E., Rubartelli A., The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Reports 2002 3 10 995 1001 10.1093/embo-reports/kvf198 2-s2.0-0036775236 (Pubitemid 35256475)
52. Feghali K., Iwasaki K., Tanaka K., Komaki M., MacHigashira M., Ishikawa I., Izumi Y., Human gingival fibroblasts release high-mobility group box-1 protein through active and passive pathways. Oral Microbiology and Immunology 2009 24 4 292 298 10.1111/j.1399-302X.2009.00508.x 2-s2.0-67649230571
53. Chacur M., Milligan E. D., Gazda L. S., Armstrong C., Wang H., Tracey K. J., Maier S. F., Watkins L. R., A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain 2001 94 3 231 244 10.1016/S0304-3959(01)00354-2 2-s2.0-0035215306 (Pubitemid 33145393)
54. Mangalmurti N. S., Faust H., Lo R., Lee J., Worthen G. S., Albelda S. M., LPS induced lung inflammation is mediated by the receptor for advanced glycation end products. C22. New Insights into Acute Lung Injury 2013
55. Takeda K., Akira S., Toll-like receptors in innate immunity. International Immunology 2005 17 1 1 14 10.1093/intimm/dxh186 2-s2.0-12444341944
56. Yamakawa N., Uchida T., Matthay M. A., Makita K., Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2011 300 4 L516 L525 10.1152/ajplung.00118.2010 2-s2.0-79955053625
57. Zhang H., Tasaka S., Shiraishi Y., Fukunaga K., Yamada W., Seki H., Ogawa Y., Miyamoto K., Nakano Y., Hasegawa N., Miyasho T., Maruyama I., Ishizaka A., Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. American Journal of Respiratory and Critical Care Medicine 2008 178 4 356 362 10.1164/rccm.200707-1069OC 2-s2.0-48949095796
58. Durand S. H., Roméas A., Carrouel F., Colomb E., Vincent C., Magloire H., Couble M., Bleicher F., Staquet M. J., Lebecque S., Farges J. C., Lipoteichoic acid increases TLR and functional chemokine expression while reducing dentin formation in in vitro differentiated human odontoblasts. Journal of Immunology 2006 176 5 2880 2887 10.4049/jimmunol.176.5.2880 2-s2.0-33644514010
59. Sugawara S., Yang S., Iki K., Hatakeyama J., Tamai R., Takeuchi O., Akashi S., Espevik T., Akira S., Takada H., Monocytic cell activation by nonendotoxic glycoprotein from Prevotella intermedia ATCC 25611 is mediated by toll-like receptor 2. Infection and Immunity 2001 69 8 4951 4957 10.1128/IAI.69.8.4951-4957.2001 2-s2.0-0034912422 (Pubitemid 32674478)
60. 4 mediates LPS-induced VEGF expression in odontoblasts. Journal of Endodontics 2006 32 10 951 955 10.1016/j.joen.2006.03.018 2-s2.0-33748564675 (Pubitemid 44374725)
61. Ramasamy R., Yan S. F., Schmidt A. M., Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications. Annals of the New York Academy of Sciences 2011 1243 1 88 102 10.1111/j.1749-6632.2011.06320. x 2-s2.0-84255163024
62. Steenvoorden M. M. C., Toes R. E. M., Ronday H. K., Huizinga T. W. J., DeGroot J., RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitro. Clinical and Experimental Rheumatology 2007 25 5 740 742 2-s2.0-37349019388 (Pubitemid 350284847)
63. Shi D. Y., Bierhaus A., Nawroth P. P., Stern D. M., RAGE and Alzheimer's disease: a progression factor for amyloid- β -induced cellular perturbation? Journal of Alzheimer's Disease 2009 16 4 833 843 10.3233/JAD-2009-1030 2-s2.0-67649739088
64. Riehl A., Németh J., Angel P., Hess J., The receptor RAGE: bridging inflammation and cancer. Cell Communication and Signaling 2009 7, article 12 10.1186/1478-811X-7-12 2-s2.0-77955769241
65. Ziegelbauer K., Gantner F., Lukacs N. W., Berlin A., Fuchikami K., Niki T., Sakai K., Inbe H., Takeshita K., Ishimori M., Komura H., Murata T., Lowinger T., Bacon K. B., A selective novel low-molecular-weight inhibitor of I B kinase- β (IKK- β) prevents pulmonary inflammation and shows broad anti-inflammatory activity. British Journal of Pharmacology 2005 145 2 178 192 10.1038/sj.bjp.0706176 2-s2.0-19944374141 (Pubitemid 40756522)
66. Tokuda M., Miyamoto R., Nagaoka S., Torii M., Substance P enhances expression of lipopolysaccharide-induced inflammatory factors in dental pulp cells. Journal of Endodontics 2004 30 11 770 774 10.1097/00004770-200411000- 00005 2-s2.0-8344260661 (Pubitemid 39481781)
67. Penzo M., Molteni R., Suda T., Samaniego S., Raucci A., Habiel D. M., Miller F., Jiang H.-., Li J., Pardi R., Palumbo R., Olivotto E., Kew R. R., Bianchi M. E., Marcu K. B., Inhibitor of NK- B kinases α and β are both essential for high mobility group box 1-mediated chemotaxis. The Journal of Immunology 2010 184 4497 4509 10.4049/jimmunol.1090039 2-s2.0-77955974261